Altimmune Inc (ALT) 11.7 -0.07 (-0.59%)
11.7 -0.07 (-0.59%)
US02155H2004 - Common Stock - After market: 11.69 -0.01 (-0.09%)
Buy % Consensus
Analysts have set a mean price target of 23.61. This target is 101.76% above the current price.
ALT was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALT.
In the previous month the buy percentage consensus was at a similar level.
ALT was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-18 | Piper Sandler | Maintains | Overweight |
| 2021-06-30 | JMP Securities | Maintains | Market Outperform |
| 2021-06-30 | B. Riley Securities | Maintains | Buy |
| 2021-06-30 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-16 | JMP Securities | Maintains | Market Outperform |
| 2021-06-02 | HC Wainwright & Co. | Initiate | Buy |
| 2021-02-11 | Guggenheim | Initiate | Buy |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA